Specifically, PLEKHA4 expression was significantly elevated in CHOL, diffuse large B-cell lymphoma (DLBC), GBM, KIRC, KIRP, LGG, pancreatic adenocarcinoma (PAAD), skin cutaneous melanoma (SKCM), STAD, testicular germ cell tumors (TGCT), THCA, and thymoma (THYM). Here, PLEKHA4 is linked to glioblastoma.